The Lubrizol Corporation, which acquired Ben Franklin client Particle Sciences, will invest millions to add commercial drug product manufacturing at the company’s facility in Bethlehem. Leveraging the company’s knowledge in complex formulations and production, the new space is expected to be operational in the fourth quarter of 2017. More: http://prn.to/2sgCKE1
Client & Alumni News
Lubrizol Invests Millions to Expand Particle Sciences
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.